Skip to main content

Table 2 Changes in adiposity measures, body composition, and other cardiometabolic risk factors following the low-calorie diet interventiona

From: Low-calorie diets and remission of type 2 diabetes in Chinese: phenotypic changes and individual variability

 

n

Baseline

3 months

Intervention effect

 

n

Baseline

6 months

Intervention effect

Mean (SD)

Mean (SD)

Differenceb (95% CI)

 

Mean (SD)

Mean (SD)

Differenceb (95% CI)

Adiposity measures

         

 Body mass index, kg/m2

32

29.8 (5.4)

26.0 (5.3)

-3.7 (-4.3 to -3.2)

 

32

29.8 (5.4)

26.3 (5.5)

-3.4 (-4.1 to -2.7)

 Waist circumference, cm

32

102.5 (13.9)

91.6 (14.1)

-10.8 (-12.9 to -8.8)

 

32

102.5 (13.9)

91.3 (13.7)

-11.2 (-13.6 to -8.8)

 Hip circumference, cm

32

105.2 (12.6)

97.1 (11.6)

-8.1 (-10.0 to -6.3)

 

32

105.2 (12.6)

97.7 (10.5)

-7.5 (-9.6 to -5.4)

 Biceps skinfold, mm

29

15.8 (6.9)

11.0 (5.0)

-4.9 (-6.8 to -2.9)

 

29

15.8 (6.9)

11.1 (3.7)

-4.7 (-6.8 to -2.7)

 Triceps skinfold, mm

29

18.3 (7.5)

12.9 (4.1)

-5.3 (-7.5 to -3.2)

 

29

18.3 (7.5)

13.3 (4.7)

-4.9 (-7.1 to -2.7)

 Subscapular skinfold, mm

29

25.9 (6.8)

20.6 (4.6)

-5.4 (-7.3 to -3.5)

 

29

25.9 (6.8)

21.8 (5.1)

-4.1 (-6.2 to -2.0)

 Suprailiac skinfold, mm

30

22.6 (7.4)

14.8 (5.4)

-7.7 (-10.5 to -4.9)

 

30

22.6 (7.4)

14.5 (5.1)

-8.1 (-10.5 to -5.6)

Body composition

         

 Body fat percentage, %

30

32.8 (9.2)

28.2 (9.9)

-4.6 (-6.3 to -2.9)

 

30

32.3 (8.9)

27.2 (9.6)

-5.1 (-7.4 to -2.7)

 Body muscle percentage, %

30

61.9 (9.8)

67.7 (9.7)

5.7 (4.5 to 7.0)

 

30

62.5 (9.5)

68.6 (9.7)

6.1 (4.2 to 8.0)

HOMA2 indexes

         

 HOMA2-IR

29

2.6 (1.3)

1.7 (0.6)

-0.9 (-1.3 to -0.5)

 

32

2.6 (1.3)

2.0 (0.9)

-0.6 (-1.0 to -0.2)

 HOMA2-%B

29

101.9 (53.3)

126.4 (52.8)

24.4 (3.3 to 45.5)

 

32

101.4 (53.4)

108.3 (45.2)

6.8 (-9.5 to 23.2)

 HOMA2-%S

28

46.6 (18.2)

68.2 (24.3)

21.7 (16.5 to 26.8)

 

32

45.7 (17.5)

59.9 (24.5)

14.2 (6.6 to 21.8)

Blood pressure, mm Hg

         

 Systolic blood pressure

32

128.7 (14.9)

118.8 (14.3)

-9.9 (-16.2 to -3.6)

 

32

128.7 (14.9)

122.1 (17.0)

-6.6 (-12.6 to -0.6)

 Diastolic blood pressure

32

84.1 (9.0)

78.6 (9.0)

-5.5 (-9.7 to -1.3)

 

32

84.1 (9.0)

79.3 (10.0)

-4.8 (-8.6 to -1.1)

Serum lipids, mmol/L

         

 Total cholesterol

32

5.2 (1.5)

4.6 (1.0)

-0.6 (-1.0 to -0.2)

 

32

5.2 (1.5)

4.9 (0.9)

-0.3 (-0.8 to 0.2)

 LDL-C

29

3.4 (0.7)

3.0 (0.8)

-0.3 (-0.6 to -0.1)

 

32

3.3 (0.7)

3.2 (0.7)

-0.2 (-0.4 to 0.0)

 HDL-C

28

1.0 (0.2)

1.1 (0.2)

0.0 (-0.0 to 0.1)

 

31

1.0 (0.2)

1.2 (0.2)

0.2 (0.1 to 0.2)

 Triglycerides

29

2.0 (0.9)

1.2 (0.4)

-0.7 (-1.0 to -0.5)

 

32

2.0 (0.8)

1.4 (0.9)

-0.5 (-0.8 to -0.3)

 Small dense LDL-C

27

1.1 (0.5)

0.8 (0.3)

-0.4 (-0.6 to -0.2)

 

30

1.1 (0.5)

0.9 (0.3)

-0.2 (-0.4 to -0.1)

 Free fatty acids

29

0.7 (1.0)

0.5 (0.2)

-0.2 (-0.6 to 0.2)

 

32

0.7 (1.0)

0.4 (0.1)

-0.3 (-0.6 to 0.0)

  1. Abbreviations: HDL-C, high-density lipoprotein cholesterol; HOMA2, Homeostasis Model Assessment 2; IR, insulin resistance; LDL-C, low-density lipoprotein cholesterol; SD, standard deviation; %B, beta-cell function; %S, insulin sensitivity
  2. a Results by the type of low-calorie diets are shown in Table S3
  3. b Differences were estimated using the paired-t test